Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences Track

Tracer kinetic analysis of the SV2A ligand 11C-UCBA as a PET marker for synaptic density in humans

Mark Lubberink, Lieuwe Appel, Johannes Daging, Karolina Lindskog, Torsten Danfors, Elna-Marie Larsson, Eva Kumlien and Gunnar Antoni
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 631;
Mark Lubberink
1Uppsala University Uppsala Sweden
2Uppsala University Uppsala Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lieuwe Appel
1Uppsala University Uppsala Sweden
2Uppsala University Uppsala Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes Daging
1Uppsala University Uppsala Sweden
2Uppsala University Uppsala Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karolina Lindskog
1Uppsala University Uppsala Sweden
2Uppsala University Uppsala Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Torsten Danfors
1Uppsala University Uppsala Sweden
2Uppsala University Uppsala Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elna-Marie Larsson
1Uppsala University Uppsala Sweden
2Uppsala University Uppsala Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva Kumlien
1Uppsala University Uppsala Sweden
2Uppsala University Uppsala Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gunnar Antoni
1Uppsala University Uppsala Sweden
2Uppsala University Uppsala Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tracer kinetic analysis of the SV2A ligand 11C-UCBA as a PET marker for synaptic density in humans
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Tracer kinetic analysis of the SV2A ligand 11C-UCBA as a PET marker for synaptic density in humans
Mark Lubberink, Lieuwe Appel, Johannes Daging, Karolina Lindskog, Torsten Danfors, Elna-Marie Larsson, Eva Kumlien, Gunnar Antoni
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 631;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Tracer kinetic analysis of the SV2A ligand 11C-UCBA as a PET marker for synaptic density in humans
Mark Lubberink, Lieuwe Appel, Johannes Daging, Karolina Lindskog, Torsten Danfors, Elna-Marie Larsson, Eva Kumlien, Gunnar Antoni
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 631;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences Track

  • Impact of cognitive reserve in frontotemporal dementia illustrated by FDG-PET.
  • Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with 18F-FEOBV
  • Kinetic evaluation of [18F]MOZAT PET imaging in humans.
Show more Neurosciences Track

Novel Clinical Applications in Tauopathy and Epilepsy

  • Reduced SV2A binding in the seizure onset zone in temporal lobe epilepsy patients - A PET study with 11C-UCB-J
  • PET/MR and preoperative localization of seizure foci in patients with medication-refractory epilepsy
  • Comparison of regional flortaucipir PET SUVr values to quantitative tau histology and quantitative tau immunoassay in patients with Alzheimer’s disease pathology: A clinico-pathological study
Show more Novel Clinical Applications in Tauopathy and Epilepsy

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire